|Articles|July 27, 2016
INC Research Launches Vaccine Catalyst Site Network
INC Research announces the launch of its Vaccine Catalyst Site Network.
Advertisement
INC Research announces the launch of its Vaccine Catalyst Site Network. This initiative is part of INC’s Catalyst program introduced earlier this year to strengthen collaborations with worldwide clinical research sites, patient focus and study delivery.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Genentech’s Phase III MEERKAT and SANDCAT Trials Show Vision and Anatomical Gains With Vamikibart in Uveitic Macular Edema
2
Honing the Power of AI for Next Generation Trial Oversight and Execution
3
ACT Brief: AI-Driven Oversight, Biotech Acceleration Strategies, and a Major Win in Bladder Cancer
4
AstraZeneca’s Phase III POTOMAC Trial Shows Imfinzi Significantly Improves Disease-Free Survival in High-Risk NMIBC
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
